Arcturus Therapeutics Holdings Inc (ARCT)
16.02
-2.32
(-12.65%)
USD |
NASDAQ |
Nov 15, 16:00
16.25
+0.23
(+1.44%)
After-Hours: 16:46
Arcturus Therapeutics Holdings Net Income (TTM): -62.64M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | -62.64M |
| June 30, 2024 | -71.96M |
| March 31, 2024 | -107.30M |
| December 31, 2023 | -29.72M |
| September 30, 2023 | 99.33M |
| June 30, 2023 | 80.28M |
| March 31, 2023 | 111.27M |
| December 31, 2022 | 9.349M |
| September 30, 2022 | -146.66M |
| June 30, 2022 | -165.48M |
| March 31, 2022 | -198.50M |
| December 31, 2021 | -203.67M |
| September 30, 2021 | -196.12M |
| June 30, 2021 | -163.04M |
| March 31, 2021 | -118.72M |
| December 31, 2020 | -72.15M |
| September 30, 2020 | -52.03M |
| June 30, 2020 | -38.46M |
| March 31, 2020 | -28.88M |
| December 31, 2019 | -25.99M |
| September 30, 2019 | -16.01M |
| June 30, 2019 | -12.83M |
| March 31, 2019 | -22.10M |
| December 31, 2018 | -21.78M |
| Date | Value |
|---|---|
| September 30, 2018 | -26.05M |
| June 30, 2018 | -24.98M |
| March 31, 2018 | -16.13M |
| December 31, 2017 | -13.08M |
| September 30, 2017 | 9.309M |
| June 30, 2017 | 4.684M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | -1.571M |
| September 30, 2016 | -6.016M |
| June 30, 2016 | -2.476M |
| March 31, 2016 | -1.811M |
| December 31, 2015 | -1.902M |
| September 30, 2015 | -21.36M |
| June 30, 2015 | -27.59M |
| March 31, 2015 | -30.24M |
| December 31, 2014 | -32.83M |
| September 30, 2014 | -31.74M |
| June 30, 2014 | -24.38M |
| March 31, 2014 | -17.94M |
| December 31, 2013 | -10.55M |
| September 30, 2013 | -5.139M |
| June 30, 2013 | -2.294M |
| March 31, 2013 | -1.395M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-203.67M
Minimum
Dec 2021
111.27M
Maximum
Mar 2023
-69.05M
Average
-67.30M
Median
Net Income (TTM) Benchmarks
| Fulcrum Therapeutics Inc | -20.23M |
| Bioventus Inc | -39.48M |
| Liquidia Corp | -112.11M |
| Pfizer Inc | 4.252B |
| AIM ImmunoTech Inc | -28.04M |